Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Most readers would already be aware that Privia Health Group's (NASDAQ:PRVA) stock increased significantly by 13% over the past three months. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. Particularly, we will be paying attention to Privia Health Group's ROE today.
大多数读者都已经知道,Privia Health Group(纳斯达克:PRVA)的股价在过去三个月中显著增长了13%。由于大多数人知道,基本面通常引导长期市场价格走势,所以我们决定今天查看公司的关键财务指标,以确定它们是否在最近的价格运动中发挥任何作用。特别是,我们今天将关注Privia Health Group的roe。
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
股东权益回报率(ROE)是测试公司如何有效地增加其价值并管理投资者资金的指标。简而言之,它用于评估公司相对于股本资本的盈利能力。
How Is ROE Calculated?
净资产收益率怎么计算?
The formula for ROE is:
roe的公式是:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
净资产收益率 = 净利润(从持续经营中获得)÷ 股东权益
So, based on the above formula, the ROE for Privia Health Group is:
所以,根据上述公式,Privia Health Group的ROE为:
2.5% = US$16m ÷ US$644m (Based on the trailing twelve months to June 2024).
2.5%= US $ 1600万 ÷ US $ 64400万(截至2024年6月的过去十二个月)。
The 'return' is the profit over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.02.
“回报”是过去十二个月的利润。这意味着,对于每1美元的股东投资,公司可以产生0.02美元的利润。
Why Is ROE Important For Earnings Growth?
ROE为什么对净利润增长很重要?
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
我们已经确定ROE作为评估公司未来收益的有效指标。现在我们需要评估公司为未来增长所保留的利润量,从而给我们一个关于公司增长潜力的想法。假设其他条件都相同,既具有较高ROE又具有较高利润保留的公司通常是增长率更高的公司,相比之下没有这些特点的公司会更低。
Privia Health Group's Earnings Growth And 2.5% ROE
Privia Health Group的盈利增长和2.5%的roe
It is quite clear that Privia Health Group's ROE is rather low. Not just that, even compared to the industry average of 12%, the company's ROE is entirely unremarkable. However, we we're pleasantly surprised to see that Privia Health Group grew its net income at a significant rate of 34% in the last five years. Therefore, there could be other reasons behind this growth. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio.
很明显,Privia Health Group的roe相当低。不仅如此,即使与12%的行业平均水平相比,该公司的roe也完全平凡。但是,我们惊喜地发现,过去五年中,Privia Health Group将其净收入增长了34%。因此,这种增长可能还有其他原因。例如,公司的管理层可能已经做出了一些明智的战略决策,或者公司的股息支付比率很低。
We then compared Privia Health Group's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 7.1% in the same 5-year period.
然后,我们将Privia Health Group的净收入增长率与行业进行了比较,很高兴看到公司的增长率比同一5年期内增长率为7.1%的整个行业更高。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240815/0-17dc98f6ee6138c1b91d977de59a3f23-0-740c69cc5e7675f1a0468d5459e7c6c4.png/big)
Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if Privia Health Group is trading on a high P/E or a low P/E, relative to its industry.
盈利增长是考虑股票价值时需要考虑的重要指标。接下来,投资者需要确定的是,预期的盈利增长或缺乏盈利增长是否已经构建到股价中。这样做,他们将了解股票是进入清澈的蓝色水域还是等待泥泞的水域。预期盈利增长的一个很好的指标是市盈率,它根据公司的盈利前景决定市场愿意为一只股票支付的价格。因此,您可能希望查看Privia Health Group相对于其行业是在高PE还是低PE交易。
Is Privia Health Group Using Its Retained Earnings Effectively?
Privia Health Group是否正在有效利用其留存收益?
Privia Health Group doesn't pay any regular dividends to its shareholders, meaning that the company has been reinvesting all of its profits into the business. This is likely what's driving the high earnings growth number discussed above.
Privia Health Group没有向股东支付任何定期股息,这意味着该公司一直将其所有利润再投资于业务中。这很可能是上述高盈利增长率的驱动因素。
Summary
总的来说,我们对伟明环保的表现非常满意。具体而言,我们喜欢公司以高回报率再投资了其利润的很大一部分。当然,这导致公司的收益大幅增长。但是,最新的行业分析师预测表明,该公司的收益预计将加速增长。
On the whole, we do feel that Privia Health Group has some positive attributes. Even in spite of the low rate of return, the company has posted impressive earnings growth as a result of reinvesting heavily into its business. We also studied the latest analyst forecasts and found that the company's earnings growth is expected be similar to its current growth rate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
总体而言,我们确实认为Privia Health Group具有一些积极的特征。尽管回报率低,但由于大规模再投资其业务,该公司发布了令人瞩目的盈利增长。我们还研究了最新的分析师预测,发现公司的盈利增长预计与其当前的增长率相似。要了解有关该公司未来盈利增长预测的更多信息,请查看此免费报告,了解分析师对该公司的预测。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。